ARSTRACT
Components of the renin-angiotensin system have been found in a variety of tissues during fetal and postnatal life and appear to be developmentally regulated. We postulated that hormonal changes associated with parturition participate in the regulation of renin, angiotensinogen (Ao) and angiotensin type 1 receptor (AT,) gene expression. Cortisol, which increases rapidly in fetal blood before delivery, has been shown to influence the maturation of various systems in the developing fetus. To test the hypothesis that an increase in cortisol regulates fetal renin, Ao, and AT, mRNA gene expression, we used Northern blot analysis to study the effects of an intraperitoneal infusion of cortisol (3 mglh, 1 mL/h) for 48 h on the expression of these genes in twin ovine fetuses (n = 10 pairs) at 130-d gestation (term 145 d); one twin in each pair served as a saline-treated control (0.9% NaC1, 1 mL/h). Plasma cortisol levels were significantly higher in cortisol-treated fetuses (113 5 23 nmol/dL) than in twin controls (4.6 5 0.8 nmol/dL). Cortisol infusion significantly decreased AT, receptor mRNA levels in kidney and liver by 24 i 7% and 27 i 8%, respectively, when compared with The RAS has been established to be an important regulator of hemodynamic and fluid and electrolyte homeostasis during fetal, newborn, and adult life. More recently, it has been suggested that the RAS exerts a major influence on cellular growth and organ differentiation (1) (2) (3) (4) . Although these effects may be mediated by circulating AII, there are reasons to believe that local RAS exist within individual organs or tissues (5) and may participate in these functions.
Studies in newborn infants (6) and newborn animals (7) have shown that the activity of the RAS increases at birth. In addition, developmental changes in the expression of several components of the RAS have recently been documented (8) (9) (10) . Despite the importance of the RAS in maintaining phys-controls (p < 0.05), whereas in contrast, increased mRNA levels (p < 0.05) in heart right atrium (91 -t 23%) and ventricle (59 5 20%). Renin mRNA levels decreased in renal cortex by 77 t 13% (p < 0.05) in cortisol-treated animals compared with controls. Hepatic Ao mRNA levels decreased by 15 5 5% in response to cortisol (p < 0.05), whereas no significant effect was seen on renal Ao gene expression. These findings demonstrate that cortisol exhibits tissue specific positive and negative regulation of renin, Ao and AT, receptor gene expression during fetal life and may act as an important modulator of the reninangiotensin system during parturition. (Pediatr Res 37: 741-746, 1995) Abbreviations AII, angiotensin I1 Ao, angiotensinogen AT,, angiotensin I1 type 1 receptor PRA, plasma renin activity RAS, renin-angiotensin system iologic homeostasis, few studies have investigated the factors regulating developmental changes in the expression of these genes. We have previously demonstrated that renal innervation is vital to the increase in kidney renin mRNA expression at birth (ll), but has no effect on renal AT, receptor gene expression in 24-h-old newborn lambs (12). Studies in rats have demonstrated that maternal dexamethasone administration enhances expression of the Ao gene during fetal life (8);
however, fetal sheep liver Ao and renal AT, gene expression are negatively regulated by glucocorticoids (12, 13).
The present study was designed to investigate whether cortisol, which is known to increase rapidly in fetal blood before delivery (14) and influence the maturation of various system: in the developing fetus (15), regulates gene expression of several components of the RAS in fetal ovine tissues. Arterial hemodynamic and hormonal values from the animals in this study, and the effect of cortisol on renal AT, receptor mRNA levels have recently been published elsewhere (12) and thus only directly pertinent values are included in this text.
METHODS
Animal preparation and surgical procedures. Studies were performed in 10 pairs of twin fetal sheep at 130-d gestation, term being 145 d. Pregnant ewes of Dorset and Suffolk mixed breeding were obtained from a local source; gestational ages were based on the induced ovulation technique as previously described (16).
Surgical preparatioiz. Anesthesia and surgery of the ewe and fetus were performed as previously described (1 3 , 13) . Briefly, the cwc was fasted for 24 h before surgery and anesthetized using a mixture of halothane (I%), oxygen (33%), and nitrous oxide (66%). Under sterile conditions, the uterus was opened over the fetal hindlimbs and polyethylene catheters were placed into the fetal femoral arteries and vcins bilaterally. A catheter for recording amniotic pressure was secured to the fetal skin. Additional catheters were placed in the peritoneal cavity of each twin.
At thc end of surgery, the fetal skin incisions were closed and the fetus was returned to the uterus. Maternal incisions were closed in separate layers. All catheters were exteriorized through a s.c. tunnel and placed in a cloth pouch on the ewe's flank. Ampicillin sodium (Wyeth Laboratories, Philadelphia, PA) was administered to the ewe intramuscularly before surgery (2 g) and infused into the amniotic cavity after surgery (2 g). Pregnant ewes were returned to individual pens and allowed free access to food and water. The animals were allowed 3 d to recover from surgery before beginning the experiments. All procedures were performed within the regulations of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the University of Iowa Animal Care and Use Committee.
Experiinental protocol. After a 3-d recovery period from surgery, one of each set of twins was administered a continuous intraperitoneal infusion of cortisol for exactly 48 h at a rate of 3 mg/h (1 mL/h). The other twin served as a paired control and received an intraperitoneal infusion of 0.9% NaCl at a similar rate (1 mL/kg). The infusions were carried out with portable constant infusion pumps (Cormed, Inc., Middleport, NY) secured on the back of the ewe in pockets of a specially designed jacket that allowed the animals to move freely during the infusion.
Arterial blood pressure, heart rate, and amniotic pressure were monitored in each fetus for 30 min immediately before and at the end of the 48 h intraperitoneal infusion. Arterial blood from each fetus was taken before and 48 h after starting the cortisol infusion for determination of arterial pH, Pco,, Po,, plasma cortisol and AT1 concentrations, and PRA. This duration of infusion was chosen as in vitro studies investigating the effects of glucocorticoids on the vascular smooth muscle AT, receptor showed a maximal increase in AT, receptors at 48 h (17). At the end of the infusion period, ewes were anesthetized as described above, the uterine cavity was opened, and sections of heart (all four chambers), peripheral lung, liver, adrenal, and renal cortex were removed, snap frozen in liquid nitrogen, and stored at 7 0°C .
Isolatiorz of RNA and preparation of probes. Total cellular RNA was extracted using a modified isothyiocyanate-CsCl method as previously described (9). RNA concentrations were determined spectrophotometrically by absorbance at 260 nm. RNA samples were stored as an ethanol precipitate at -70°C until further analysis.
All experiments were performed with RNA probes complimentary to the sequences of interest. A clone containing fulllength rat Ao c D M (pRANG6) (1 8) was obtained from Dr. K.
R. Lynch (University of Virginia, Charlottesville, VA). This cDNA yields the antisense RNA when transcribed from the T7 promoter after linearization with EcoRI. A clone containing a 0.7-kb fragment of rat renin cDNA was prepared from a full-length 1.43-kb rat renin cDNA (19) also obtained from K. R. Lynch. After linearization with EcoRI, transcription from the T7 promoter yields the antisense RNA.
The sheep AT, partial cDNA was prepared as previously described by our group (12) and recloned into the SpeI and KpnI restriction sites of pBluescript I1 SK-(Stratagene) yielding the subclone PAT,. The plasmid PAT, was treated with the restriction enzyme Ndel and then purified by pheno1:chloroform:isoamyl alcohol (25:24:1) and ethanol precipitation. The resultant linear plasmid was used to generate an antisense RNA probe using T7 RNA polymerase (U.S. Biochemical Corp., Cleveland, OH). Radiolabeled probe5 were generated using D-['~P]uTP. An 1 8 s rRNA probe was used to confirm equal loading and transfer of RNA. The 1 8 s rRNA was prepared from 1 8 s cDNA clone corresponding to a 82-bp fragment of a highly conserved region of human 18S ribosomal RNA (Ambion Inc., Austin, TX).
Northern blot hybridization. Aliquots of 5-10 p g of RNA as measured by absorbance at 260 nm were fractioned by formaldehyde-argose gel electrophoresis (20). After electrophoresis, RNA was transferred to 0.45-mm Nytran filters. The filters were prehybridized for 1 h at 60°C in a solution of 50% deionized formamide, 5 X SSPE, 5 X Denhardt's reagent, 0.5% SDS, and 200 pg/mL denatured sheared salmon sperm DNA. Hybridization of filters was carried out with fresh hybridization buffer solution containing 2 X 10%ounts/min/m~ of the appropriate radiolabeled probe. The hybridization reaction was carried out at 60°C for 12-18 h.
Filters were washed according to the manufacturer's specifications. This included three low stringency washes (1 X SSPE, 0.5% SDS) at 68°C and a high stringency wash (0.1 X SSPE, 0.5% SDS) at 65°C. Hybridization signals were detected and quantitated using an AMBIS 4000 Radioanalytic Imaging System (AMBIS Inc., San Diego CA). The AMBIS 4000 simultaneously images and quantitates the radioisotopic signal generated by "P on the filters as previously described (12). Background counts above each lane were determined and subtracted from the total counts generated in each region of interest to yield a net count value. The washed filters were additionally exposed to Kodak XAR film at -70°C.
The filters used for the determination of AT, mRNA were also used to probe for renin mRNA and Ao mRNA. Before rehybridizing with a second RNA probe, the first RNA probe was stripped from the filters by washing in a solution of 50% REGULATION OF THE RENIN-ANGIOTENSIN SYSTEM 743 formamide and 6 X SSPE at 70°C for 30 min and by rinsing in 2 X SSPE at 24°C.
Analytical procedures. Arterial blood for pH, Pco, and Po, was collected anaerobically in heparinized syringes, and measurements immediately determined using an IL-1303 pH blood gas analyzer (Laboratory Instruments, Schaumburg IL) at 39.5"C. Measurements of plasma cortisol (13) and A11 concentrations (interassay and intraasssay variabilities of 12.7 and 5.5%, respectively) (21) and PRA (interassay and intraassay variabilities of 12.1 and 7.9%, respectively) (21, 22) were performed by radioimmunoassay as previously established in our laboratory.
Data analysis. For quantitation of mRNA abundance, all individual tissue samples were analyzed together on a single Northern blot hybridization to control for day-to-day variations in hybridization efficiency. Northern blots were done in triplicate. Abundances of AT,, renin and Ao mRNA were expressed as total net radioactive counts after subtracting background counts for each sample.
Comparisons of arterial blood and hemodynamic values among groups were performed using one-way analysis of variance. If the F statistic was found to be significant, comparisons among means was performed by the Duncan multiple comparison procedure (23). Comparisons of mRNA abundance between groups were performed by paired t tests. Statistical significance is defined a s p < 0.05, and results are presented as mean + SEM.
RESULTS
The effects of cortisol infusion on systemic hemodynamics and arterial blood values have previously been published (12). Fetal plasma cortisol concentrations were similar in both groups before cortisol infusion (2.3 -t 0.4 versus 3.2 + 0.7 nmolldl for control and treated groups, respectively). Cortisoltreated fetuses had significantly higher ( p < 0.001) plasma cortisol values at 48 h (112.6 + 23.1 nmolldl) compared with control fetuses (4.6 + 0.8 nmol/dL). PRA decreased significantly from 5.47 ? 1.26 to 1.21 2 0.32 ng AIlmLIh in cortisol treated fetuses, whereas no changes were detected in plasma A11 levels in either group. Mean arterial blood pressure was similar between groups.
Effects of cortisol infusion on AT,, renin and Ao mRNA levels. We postulated that cortisol, which increases rapidly in fetal blood before birth (14), and is known to influence the maturation of various systems in the developing animal (15), regulates the increased activity of the RAS seen at birth (7, 11).
The effects of cortisol administration on AT, mRNA levels are shown in Table 1 and Figure 1 . Northern blot hybridization demonstrated significant decreases in renal and hepatic AT, mRNA levels in cortisol-treated fetuses of 24 + 7% and 27 + 8%, respectively, compared with controls. In contrast, cardiac AT, mRNA levels increased in response to cortisol infusion. Right atrium AT, mRNA increased 91 ? 23% when compared with saline-treated controls, whereas right ventricle and left atrium AT, mRNA increased by 59 + 20% and 37 + 12%, respectively. No significant changes in AT, mRNA levels were seen in the left ventricle or adrenal tissues. The response of fetal renin mRNA levels to plasma cortisol infusion are shown in Table 1 and Figure 2 . The Northern blot analysis demonstrates that cortisol administration resulted in decreased kidney renin mRNA levels. Total net 3 2~ radioactive counts demonstrated that cortisol administration resulted in a 77 t 13% decrease in kidney renin mRNA ( p < 0.05) and a 31 2 20% increase in adrenal ( p = 0.055) renin mRNA. As shown by Northern blot analysis, cortisol administration also decreased hepatic Ao mRNA levels by 15 + 5% compared with controls, whereas no significant effect was seen on kidney Ao mRNA abundance. Hybridization to an 1 8 s rRNA probe showed no significant differences between control and cortisoltreated fetuses for any tissue type (Table 2) , indicating similar RNA loading. Levels of renin mRNA by Northern blot analyses were too low for accurate quantitation in lung, heart, and liver, and for Ao mRNA in lung, heart, or adrenal tissue.
DISCUSSION
Recent findings suggest that early during development, the RAS not only regulates cardiovascular, fluid, and electrolyte homeostasis (7, 24), but also influences cellular growth and local tissue function (25, 26). Components of the RAS have been found in many extrarenal tissues (5, 27), supporting the notion of independent tissue RAS and locally generated angiotensins regulating cellular differentiation and function. In the present study, we hypothesized that cortisol, which increases rapidly before delivery and further with birth (14, 28) and has previously been shown to influence the maturation of various expressed as total net counts of 3 
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. cifically, a rise in fetal plasma cortisol concentration to levels similar to those observed at the time of parturition produced a decrease in renal and hepatic but an increase in cardiac AT, mRNA levels. In addition, renal renin mRNA and hepatic Ao mRNA levels were attenuated. The AT, receptor is abundantly expressed late during fetal development (25) and in the rat is predominantly located in areas related to blood pressure regulation and fluid and electrolyte homeostasis (25). Not surprisingly, it is during this period of development that A11 becomes an important modulator of blood pressure (7, 24). For example, studies have shown that inhibition of A11 synthesis, using captopril, affects blood pressure and renal hemodynamic responses to hemorrhage in near-term fetal and newborn sheep but not earlier during fetal development (7, 29). In addition, antenatal blockade of the RAS significantly reduces resting blood pressure in near-term fetal sheep (7) and negates the normal rise in arterial pressure after birth (30).
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In support of the hypothesis that cortisol regulates AT, mRNA levels during fetal life, in vitro studies have shown that dexamethasone increases AT, gene expression in adult rat cultured vascular smooth muscle cells (17), this effect being blocked by a glucocorticoid antagonist. Our observation that cortisol administration increased cardiac AT, mRNA levels is consistent with these previous results. On the other hand, cortisol infusion decreased renal and hepatic AT, mRNA levels. The kidney AT, data were derived independently of that already published (12) (thus explaining the slight differences in values) and replicates, but does not duplicate these results. Other investigators have similarly found that corticosteroids down-regulate rat glomerular A11 receptors (31) and AT, receptors in pancreatic acinar cells (32). One may therefore conclude that AT, gene expression is differentially regulated by cortisol in a tissue-specific manner. It should be noted, however, that changes in AT, mRNA levels do not necessarily reflect alterations in the abundance of AT, receptor protein. Recent studies in rats have shown that AT, mRNA in renal cortex is present before AT, receptor ligand binding (33). Further studies are required to determine the relationship between AT, mRNA levels and receptor density in developing animals.
The effect of cortisol on the distribution of AT, receptor mRNA within specific tissue types was not addressed in the present study. Given the effect of corticosteroids on enhancing maturation in other tissues (15), one may speculate that cortisol induced developmental changes in the distribution of AT, mRNA. In the rat, the intrarenal distribution of AT, mRNA changes with maturation (lo), becoming absent in the nephrogenic cortex, and more discretely localized to glomeruli, arteries and vasa recta. AT, gene expression in renal tubules, however, remains low throughout ontogeny (34). Hence, the observed decrease in renal cortical mRNA levels in the present study may represent down-regulation of AT, mRNA at specific sites within the kidney.
Increased plasma cortisol concentrations also produced tissue specific differential regulation of renin mRNA, decreasing renin mRNA levels in the kidney, whereas mRNA levels in the adrenal remain unchanged. Tissue-specific regulation of several components of the RAS has previously been reported (5, 27). Dzau and colleagues (27) found in mice that sodium depletion increases renin mRNA levels in kidney, heart and adrenal but not in the testis or submandibular gland. Additional studies in rats have shown that bilateral nephrectomy and combined hormone therapy produce a greater than 2-fold increase in liver Ao mRNA levels but decrease mRNA levels in aorta, adrenal and lung (5). Mechanisms by which cortisol produces differential regulation of genes of the RAS were not investigated, although several explanations can be suggested. Cortisol infusion may secondarily alter the local production of growth factors which act in a tissue specific manner to regulate gene transcription or stability (13). For example, it has recently been shown that the induction of specific growth factors account for the mitogenic effects of A11 on vascular smooth muscle as these effects are blocked by the growth factor inhibitor suramin (3). Second, cellular-specific developmental changes in the physiochemical nature of glucocorticoid receptor, including receptor density and the presence of nonfunctional or modified receptors may alter the cellular sensitivity to glucocorticoids (35). In the 5'-flanking regions of the renin and Ao genes, glucocorticoid responsive elements have been identified that are thought to regulate gene expression (2) . However, the positive or negative glucocorticoid regulation of gene expression likely depends on other factors interacting with the glucocorticoid regulatory elements. In mice, the presence of the oncogene c-jun confers a positive glucocorticoid effect to the glucocorticoid regulatory element, whereas the combination of c-jun and c-fos tends to confer a negative effect to the same element (36). Furthermore, it should be noted that cortisol exhibits both glucocorticoid and mineralocorticoid properties, the interaction of which may alter the regulation of certain genes. Indeed, the regulation of gene expression by mineralocorticoids may itself be tissue-and cell-specific as they have been shown to up-regulate A11 receptors in neurons (37) while producing down-regulation of glomerular A11 receptors (31). Clearly, additional studies are needed to clarify these issues. The finding that an increase in plasma cortisol concentration decreased liver Ao mRNA levels in fetal sheep is in contrast to findings in mature animals (5) and fetal rats (8) in which glucocorticoids increase Ao mRNA accumulation. Reasons for these differences are not clear, but maybe due to the pharmacologic differences of cortisol versus dexamethasone or differences in species. There is clear evidence that species differences exist in terms of regulating expression of genes of the RAS. Hepatic Ao mRNA levels increase 3-fold from 60 to 138 d of gestation in fetal sheep, then decrease after birth (9). In contrast, liver Ao mRNA does not appear in the neonatal rat until about 24 h after birth (38). In addition, renal AT, receptor mRNA levels increase after birth in rats (10) but not sheep (12). These ontogenic differences may be due to maturational differences between sheep and rat at the time of birth, inasmuch as the newborn lamb is more mature at birth than is the rat. Nonetheless, the present results are consistent with those of a previous study by our group (13) that demonstrated cortisol administration decreased liver Ao mRNA by 61% in 138 d fetuses but had no effect in 118-d fetuses. Interestingly, only a 15% decrease in Ao mRNA was seen in the present study which used fetuses of an intermediate age (130 d) compared with those of the previous study. These results further support the hypothesis that regulation of Ao mRNA is developmentally regulated as previously suggested (13).
Recent work demonstrating local synthesis of components of the RAS in the heart supports the existence of a tissue-specific cardiac RAS (1). In the heart, renin, Ao, and angiotensinconverting enzyme gene expression has been demonstrated in several species (I), as has the existence of functional A11 receptors (1, 34) . Studies in rabbits and guinea pigs have found the angiotensin receptor density to be higher in atria than in ventricles (39), although other investigators have found AT, receptors to be equally distributed (40). In the present study, AT, mRNA levels were similar among left and right atria and ventricles. Other studies in rats have also reported essentially identical A11 receptor mRNA quantities in left and right ventricle myocytes (41). Given the purported growth promoting effects of angiotensin (1, 41), it should not be surprising to find a uniform distribution of AT, receptors within the developing fetal heart. Interestingly, Ao and renin mRNA are present in all four cardiac chambers in embryonic chick heart, but only in atria of 10-d-old chicks (42). Whether similar developmental changes in cardiac AT, mRNA expression occurs in sheep has to our knowledge not been investigated.
Renin, Ao, and AT, gene expression have been shown by other investigators to be responsive to AII, although results are not consistent and appear tissue-dependent (43, 44). We observed no significant change in circulating A11 levels in response to cortisol infusion, despite a decrease in PRA. Reasons for this phenomena have been discussed elsewhere (12). Nonetheless, one cannot ascribe the observed changes in AT, mRNA levels, or the expression of other genes of the RAS examined in this study to changes in circulating A11 levels.
In summary, our study demonstrates that cortisol differentially regulates gene expression of several components of the RAS in a tissue-specific manner early during development. These data also suggest that locally independent and biologically active RASs function at the cellular level. Further studies are needed to examine the developmental changes in localized RAS and how these systems are regulated.
